Lim, Elfamela S.

HRN: 21-74-31  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2022
CEFUROXIME 500MG (TAB)
08/02/2022
08/08/2022
PO
500mg
BID
UTI
Waiting Final Action 
08/03/2022
CEFUROXIME 1.5GM (VIAL)
08/03/2022
08/04/2022
IVT
1.5g
Q8
S/P Curettage
Waiting Final Action 
08/03/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/03/2022
08/04/2022
IVT
500mg
Q8
S/P Curettage
Waiting Final Action 
08/04/2022
CEFUROXIME 500MG (TAB)
08/04/2022
08/10/2022
ORAL
500mg
BID
S/P Completion Curretage; Abortion Complete
Waiting Final Action 
08/04/2022
CEFUROXIME 500MG (TAB)
08/04/2022
08/10/2022
ORAL
500mg
BID
S/P Completion Curretage; Abortion Complete
Waiting Final Action 
08/04/2022
CEFUROXIME 500MG (TAB)
08/04/2022
08/10/2022
ORAL
500mg
BID
S/P Completion Curretage; Abortion Complete
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: